ASTHMA, SUSCEPTIBILITY TO

Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary

Literature (2)

Literature for OMIM 600807: ASTHMA, SUSCEPTIBILITY TO

Xenbase Articles:
(

Denotes literature images)

Embryonic frog epidermis: a model for the study of cell-cell interactions in the development of mucociliary disease., Dubaissi E,Papalopulu N, Dis Model Mech. March 1, 2011; 4(2):1754-8411.
Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments., Forkuo GS,Guthrie ML,Yuan NY,Nieman AN,Kodali R,Jahan R,Stephen MR,Yocum GT,Treven M,Poe MM,Li G,Yu OB,Hartzler BD,Zahn NM,Ernst M,Emala CW,Stafford DC,Cook JM,Arnold LA, Mol Pharm. June 6, 2016; 13(6):1543-8392.

Embryonic frog epidermis: a model for the study of cell-cell interactions in the development of mucociliary disease., Dubaissi E,Papalopulu N, Dis Model Mech. March 1, 2011; 4(2):1754-8411.

Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments., Forkuo GS,Guthrie ML,Yuan NY,Nieman AN,Kodali R,Jahan R,Stephen MR,Yocum GT,Treven M,Poe MM,Li G,Yu OB,Hartzler BD,Zahn NM,Ernst M,Emala CW,Stafford DC,Cook JM,Arnold LA, Mol Pharm. June 6, 2016; 13(6):1543-8392.